Dutch MedTech company developing an autonomous robotic phlebotomy system combining robotics, multimodal imaging and AI to automate diagnostic blood draws (Aletta® ARPD™).
Investment Rounds
Capital activity and funding progression
| Amount | Date | Round |
|---|---|---|
| $70 M | Mar, 2026 | series-b |
Frequently Asked Questions
Where is Vitestro located?
Vitestro is located in Utrecht, Netherlands.
What industries does Vitestro operate in?
Vitestro operates in the following industries: medtech, robotics, medical devices, artificial intelligence, medical imaging, phlebotomy.
How much total funding has Vitestro raised?
Vitestro has raised a total of $70,000,000.
Who are the investors in Vitestro?
The investors in Vitestro are: Labcorp Venture Fund, Mayo Clinic, Sutter Health, InterVest, MGFO, PGGM, Puma, ROM Utrecht, Invest-NL, EIC Fund, Fred Moll, NYBC Ventures, Sonder Capital.
What is the primary mission of Vitestro?
Vitestro aims to modernize blood drawing by creating an autonomous device that uses robotics and artificial intelligence to perform venipuncture with high precision and consistency.
How does the Vitestro device identify the best vein for blood collection?
The device utilizes advanced ultrasound imaging combined with artificial intelligence to map out the patient's anatomy and select the most suitable vein for the procedure automatically.
What are the main advantages of using Vitestro in a clinical setting?
Key benefits include a reduction in the workload for medical staff, shorter waiting times for patients, and a standardized process that minimizes human error during blood collection.
Is the Vitestro autonomous blood-drawing system safe for patients?
The system is engineered with multiple safety layers, including real-time monitoring and sensors, to ensure the procedure is performed accurately and safely within a medical environment.
Which healthcare organizations are the primary users of Vitestro technology?
Large hospitals and diagnostic laboratories that handle a high volume of blood samples are the primary users, as the technology helps streamline their high-throughput workflows.